Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

TSX:DCBO - Toronto Stock Exchange - CA25609L1058 - Common Stock - Currency: CAD

36.21  -0.83 (-2.24%)

Fundamental Rating

6

Taking everything into account, DCBO scores 6 out of 10 in our fundamental rating. DCBO was compared to 63 industry peers in the Software industry. DCBO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCBO is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
In the past year DCBO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of DCBO (11.66%) is better than 87.30% of its industry peers.
With an excellent Return On Equity value of 43.94%, DCBO belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
With an excellent Return On Invested Capital value of 21.50%, DCBO belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROIC 21.5%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

The Profit Margin of DCBO (10.34%) is better than 80.95% of its industry peers.
The Operating Margin of DCBO (9.40%) is better than 71.43% of its industry peers.
DCBO's Gross Margin of 80.94% is amongst the best of the industry. DCBO outperforms 87.30% of its industry peers.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
DCBO has a better debt/assets ratio than last year.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.36 indicates that DCBO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.36, DCBO is doing good in the industry, outperforming 63.49% of the companies in the same industry.
The Debt to FCF ratio of DCBO is 0.04, which is an excellent value as it means it would take DCBO, only 0.04 years of fcf income to pay off all of its debts.
DCBO has a better Debt to FCF ratio (0.04) than 93.65% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that DCBO is not too dependend on debt financing.
DCBO has a better Debt to Equity ratio (0.00) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 3.36
ROIC/WACC2.24
WACC9.58%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.15. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a Current ratio of 1.15. This is comparable to the rest of the industry: DCBO outperforms 52.38% of its industry peers.
A Quick Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.15, DCBO perfoms like the industry average, outperforming 53.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 336.36%, which is quite impressive.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 16.79% in the last year.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.47%

3.2 Future

The Earnings Per Share is expected to grow by 27.76% on average over the next years. This is a very strong growth
DCBO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.94% yearly.
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.23, DCBO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 79.37% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.03, DCBO is valued at the same level.
Based on the Price/Forward Earnings ratio of 17.98, the valuation of DCBO can be described as rather expensive.
DCBO's Price/Forward Earnings ratio is rather cheap when compared to the industry. DCBO is cheaper than 85.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (21.94), we can say DCBO is valued inline with the index average.
Industry RankSector Rank
PE 27.23
Fwd PE 17.98
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DCBO.
69.84% of the companies in the same industry are more expensive than DCBO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.52
EV/EBITDA 28.44
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
DCBO's earnings are expected to grow with 21.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (5/21/2025, 7:00:00 PM)

36.21

-0.83 (-2.24%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners35.68%
Inst Owner ChangeN/A
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap1.09B
Analysts81.43
Price Target48.88 (34.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.55%
Min EPS beat(2)26.05%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)25.39%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)-11.33%
EPS beat(12)10
Avg EPS beat(12)140.75%
EPS beat(16)12
Avg EPS beat(16)97.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-0.47%
PT rev (1m)-2.04%
PT rev (3m)-13.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)62.25%
EPS NY rev (1m)0%
EPS NY rev (3m)15.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-2.19%
Valuation
Industry RankSector Rank
PE 27.23
Fwd PE 17.98
P/S 3.51
P/FCF 28.52
P/OCF 27.19
P/B 14.92
P/tB 21.22
EV/EBITDA 28.44
EPS(TTM)1.33
EY3.67%
EPS(NY)2.01
Fwd EY5.56%
FCF(TTM)1.27
FCFY3.51%
OCF(TTM)1.33
OCFY3.68%
SpS10.31
BVpS2.43
TBVpS1.71
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROCE 36.68%
ROIC 21.5%
ROICexc N/A
ROICexgc N/A
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
FCFM 12.31%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0
Cap/Depr 39.83%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 118.32%
Profit Quality 119.04%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 3.36
F-Score8
WACC9.58%
ROIC/WACC2.24
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.47%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y347.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.07%
EBIT Next 3Y58.04%
EBIT Next 5Y42.64%
FCF growth 1Y2197.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1283.74%
OCF growth 3YN/A
OCF growth 5YN/A